Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN

Delayed Quote. Delayed  - 07/29 10:00:00 pm
128.6 USD   -1.38%
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
07/28DJALEXION PHARMAC : Cuts Profit Guidance
07/28 ALEXION PHARMAC : misses 2Q profit forecasts
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/25/2016 07/26/2016 07/27/2016 07/28/2016 07/29/2016 Date
127.46(c) 126.65(c) 129.78(c) 130.4(c) 128.6(c) Last
1 382 218 1 331 610 2 110 740 2 899 315 1 888 675 Volume
+1.32% -0.64% +2.47% +0.48% -1.38% Change
More quotes
Financials ($)
Sales 2016 3 079 M
EBIT 2016 1 281 M
Net income 2016 617 M
Debt 2016 1 866 M
Yield 2016 -
Sales 2017 3 686 M
EBIT 2017 1 642 M
Net income 2017 954 M
Debt 2017 1 244 M
Yield 2017 -
P/E ratio 2016 48,72
P/E ratio 2017 31,75
EV / Sales2016 9,96x
EV / Sales2017 8,15x
Capitalization 28 809 M
More Financials
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders.It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
10/20Earnings Release
More about the company
Surperformance© ratings of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on ALEXION PHARMACEUTICALS, I
07/29 ALEXION PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
07/28 ALEXION PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fin..
07/28DJALEXION PHARMACEUTICALS : Cuts Profit Guidance
07/28 ALEXION PHARMACEUTICALS : misses 2Q profit forecasts
07/28 ALEXION PHARMACEUTICALS : Reports Second Quarter 2016 Results
07/18 ALEXION PHARMACEUTICALS : Reports Positive SBC-103 Phase 1/2 Data
07/14 ALEXION PHARMACEUTICALS : Presents New SBC-103 (rhNAGLU enzyme) Phase 1/2 Data o..
07/11 ALEXION PHARMACEUTICALS : to Report Second Quarter 2016 Results on Thursday, Jul..
07/07 ALEXION PHARMACEUTICALS : New Data from Phase 3 REGAIN Study of Eculizumab (Soli..
More news
Sector news : Biopharmaceuticals
08:48aDJMERCK : Earnings Watch -- WSJ
01:14a BAYER : says will halt future U.S. sales of insecticide
07/29DJTech Stocks Up On Google Earnings - Tech Roundup
07/29DJMERCK : Revenue Rises on Cancer, Hepatitis Treatments -- Update
07/29DJABBVIE : Results Boosted by Humira, Pipeline Growth
More sector news : Biopharmaceuticals
News from SeekingAlpha
07/28 Alexion Pharmaceuticals, Inc. 2016 Q2 - Results - Earnings Call Slides
07/28 Alexion Pharmaceuticals, Inc. (ALXN) CEO David Hallal on Q2 2016 Results - Ea..
07/28 Alexion Pharmaceuticals revenues up 18% in Q2; updates guidance
07/28 Alexion Pharmaceuticals misses by $0.04, beats on revenue
07/27 Notable earnings before Thursday?s open
Advertisement
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Technical analysis trends ALEXION PHARMACEU...
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 175 $
Spread / Average Target 36%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David L. Hallal Chief Executive Officer & Director
Leonard Bell Chairman
Julie O'Neill Executive Vice President-Global Operations
Vikas Sinha Chief Financial Officer & Executive Vice President
Martin MacKay Executive VP, Global Head-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALEXION PHARMACEUTICAL..-32.58%28 809
CSL LIMITED11.58%40 399
GRIFOLS SA-8.00%13 731
JIANGXI BOYA BIO-PHARM..--.--%2 857
BEIJING TIANTAN BIOLOG..2.92%2 787
3SBIO INC-27.96%2 547
More Results